Plain-English translation of NCT07611747 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether a carotid ultrasound — a simple, painless ultrasound scan of the arteries in your neck — can help doctors better identify which people with inflammatory arthritis (like rheumatoid arthritis or lupus) are at high risk for heart attack or stroke. If the ultrasound finds early signs of plaque buildup in your arteries, you would be treated with stronger cholesterol-lowering medication to prevent future heart problems.
People with inflammatory arthritis have a much higher risk of heart disease than the general population because chronic inflammation damages blood vessels — but standard risk assessment tools miss about half of these cases. This study tests whether adding an ultrasound scan can catch hidden heart disease risk earlier, so doctors can treat it before serious events happen.
You likely qualify if…
You likely don't qualify if…
If you're randomly assigned to the ultrasound group, you'll have one carotid ultrasound scan within 30 days of enrolling — a painless imaging test where a technician uses a small handheld device on your neck to look for plaque buildup. If plaques are found, you'll start taking a stronger cholesterol-lowering medication; if not, you'll follow standard heart disease prevention guidelines. The control group receives standard care without the ultrasound scan.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Spain